Abstract:Background Polysaccharides from marine red algae possess a variety of biological activities. And, our previous study illustrated that the agaropectin-derived oligosaccharides from Gloiopeltis furcata (SAOs) activated AMPK signaling pathway in vitro. However, the effects of SAOs on alleviating lipid accumulation in vivo and its underlying mechanism are not clear. Methods C57BL/6J mice were randomly divided into five groups of ten mice each. Control group: mice were fed a normal chow diet. And, the other four groups were continuously fed an HFD for 24 weeks to establish the obesity model. After 24 weeks, the Metf, SAOs-L, and SAOs-H groups received either metformin (225 mg/kg/d dissolved in saline) or SAOs (100 or 300 mg/kg/d dissolved in saline), while the Control and Model groups were given aliquots of saline. Saline and the drugs were given by oral gavage for the final six weeks of the experimental period. Results We found that SAOs decreased the body weight (about 3 grams) and the adiposity index (from 7 to 5) after a 6-week treatment. In addition, SAOs alleviated lipid accumulation in the liver, perirenal fat, and epididymal fat tissues. Investigation of the underlying mechanism showed that the cecal microbiota dysbiosis in HFD-fed mice were ameliorated after SAOs treatment, including significantly increasing the relative abundance of Alistipes, while reducing the relative abundance of Helicobacter. In addition, Spearman’s correlation analysis indicated that changes in the cecal microbiota could regulate lipid accumulation, oxidative stress, inflammation. Conclusions The present study confirmed that SAOs could effectively alleviate HFD-induced fat accumulation, partly through regulating cecal microbiota by fostering the preferential growth of probiotics and suppressing the relative abundance of harmful bacteria. In summary, our study illustrated that SAOs could be further developed as a potential pharmaceutical agent for obesity.

Algal polysaccharides and derivatives as potential therapeutics for obesity and related metabolic diseases

The Influence of Polysaccharides on Lipid Metabolism: Insights from Gut Microbiota

Microalgae polysaccharides ameliorates obesity in association with modulation of lipid metabolism and gut microbiota in high-fat-diet fed C57BL/6 mice

Fucoidans from Pearsonothuria Graeffei Prevent Obesity by Regulating Intestinal Lipid Metabolism and Inflammation Related Signalling Pathways

Bioactive carbohydrate polymers from marine sources as potent nutraceuticals in modulating obesity: a review

Recent Advances in Pharmaceutical Potential of Brown Algal Polysaccharides and Their Derivatives.

IDDF2021-ABS-0197 Delayed Intervention of Agaropectin-Derived Oligosaccharides Alleviate Lipid Accumulation by Modulating Intestinal Flora Homeostasis

L-Fucose-Rich Sulfated Glycans from Edible Brown Seaweed: A Promising Functional Food for Obesity and Energy Expenditure Improvement

Effects of dietary seaweed on obesity-related metabolic status: a systematic review and meta-analysis of randomized controlled trials

The therapeutic effect and possible mechanisms of alginate oligosaccharide on metabolic syndrome by regulating gut microbiota

Insights into Algal Polysaccharides: A Review of Their Structure, Depolymerases, and Metabolic Pathways

Chemically modified seaweed polysaccharides: Improved functional and biological properties and prospective in food applications.

A review on shellfish polysaccharides: Extraction, characterization and amelioration of metabolic syndrome

The Therapeutic Potential of Plant Polysaccharides in Metabolic Diseases

Algal polysaccharides: current status and future prospects

Advances in Research on the Bioactivity of Alginate Oligosaccharides

Enzymatic Preparation of Low-Molecular-Weight Laminaria Japonica Polysaccharides and Evaluation of Its Effect on Modulating Intestinal Microbiota in High-Fat-Diet-Fed Mice

Immunomodulatory effects of polysaccharides from marine algae for treating cancer, infectious disease, and inflammation

Preclinical insights into fucoidan as a nutraceutical compound against perfluorooctanoic acid-associated obesity via targeting endoplasmic reticulum stress

Novel Therapeutic Approach for Obesity: Seaweeds as an Alternative Medicine with the Latest Conventional Therapy

Polysaccharides from Lyophyllum decastes reduce obesity by altering gut microbiota and increasing energy expenditure